Tolerability of Opioid Analgesia for Chronic Pain: A Network Meta-Analysis

Zengdong Meng1, Jing Yu2, Michael Acuff3

  • 1Department of Orthopaedics, First People's Hospital of YunNan Province, YunNan, P.R. China.

Scientific Reports
|May 19, 2017
PubMed

Insights

This network meta-analysis found tapentadol and oxycodone-naloxone offer superior tolerability for chronic pain management. These opioid analgesics demonstrated fewer adverse events, less constipation, and lower withdrawal rates compared to other options.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Pain Management

Background:

  • Opioid analgesics are widely used for chronic pain.
  • Concerns exist regarding their tolerability and adverse event profiles.
  • Comparative effectiveness data on different opioids is crucial for clinical decision-making.

Purpose of the Study:

  • To evaluate and compare the tolerability of various opioid analgesics for chronic pain management.
  • To synthesize evidence from randomized-controlled trials using network meta-analysis.
  • To identify opioid treatments with favorable safety and satisfaction profiles.

Main Methods:

  • A systematic database search identified randomized-controlled trials comparing two or more opioid analgesics.
  • Bayesian network meta-analyses (NMAs) were conducted to pool direct and indirect treatment comparisons.
  • Key endpoints included adverse events, constipation, trial withdrawal rates, and patient satisfaction.

Main Results:

  • Tapentadol ranked highest for overall tolerability, showing lower incidence of adverse events and constipation, and the least trial withdrawal.
  • Oxycodone-naloxone combination demonstrated good tolerability and low withdrawal rates.
  • Patient satisfaction was highest with oxycodone-naloxone, followed by fentanyl and tapentadol.

Conclusions:

  • Tapentadol and oxycodone-naloxone exhibit superior tolerability compared to other opioids for chronic pain.
  • These agents are associated with reduced adverse events, constipation, and trial withdrawal.
  • Improved tolerability and patient satisfaction support the use of tapentadol and oxycodone-naloxone in chronic pain management.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.2K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.4K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
773